194 related articles for article (PubMed ID: 31042473)
21. The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells.
Phan RT; Dalla-Favera R
Nature; 2004 Dec; 432(7017):635-9. PubMed ID: 15577913
[TBL] [Abstract][Full Text] [Related]
22. Synergistic activity of Card11 mutant and Bcl6 in the development of diffuse large B-cell lymphoma in a mouse model.
Takahara T; Matsuo K; Seto M; Nakamura S; Tsuzuki S
Cancer Sci; 2016 Nov; 107(11):1572-1580. PubMed ID: 27560392
[TBL] [Abstract][Full Text] [Related]
23. JunD/AP-1 and STAT3 are the major enhancer molecules for high Bcl6 expression in germinal center B cells.
Arguni E; Arima M; Tsuruoka N; Sakamoto A; Hatano M; Tokuhisa T
Int Immunol; 2006 Jul; 18(7):1079-89. PubMed ID: 16702165
[TBL] [Abstract][Full Text] [Related]
24. Looping around Bcl6 in Germinal Center to Sharpen B Cell Immunity.
Hu G; Zhao K
Immunity; 2016 Sep; 45(3):459-461. PubMed ID: 27653595
[TBL] [Abstract][Full Text] [Related]
25. Immunohistochemical profile and fluorescence in situ hybridization analysis of diffuse large B-cell lymphoma in northern China.
Li T; Medeiros LJ; Lin P; Yin H; Littlejohn M; Im W; Lennon PA; Hu P; Jorgensen JL; Liang M; Guo H; Yin CC
Arch Pathol Lab Med; 2010 May; 134(5):759-65. PubMed ID: 20441508
[TBL] [Abstract][Full Text] [Related]
26. BCL6: master regulator of the germinal center reaction and key oncogene in B cell lymphomagenesis.
Basso K; Dalla-Favera R
Adv Immunol; 2010; 105():193-210. PubMed ID: 20510734
[TBL] [Abstract][Full Text] [Related]
27. BCL6 represses CHEK1 and suppresses DNA damage pathways in normal and malignant B-cells.
Ranuncolo SM; Polo JM; Melnick A
Blood Cells Mol Dis; 2008; 41(1):95-9. PubMed ID: 18346918
[TBL] [Abstract][Full Text] [Related]
28. Roles of BCL6 in normal and transformed germinal center B cells.
Basso K; Dalla-Favera R
Immunol Rev; 2012 May; 247(1):172-83. PubMed ID: 22500840
[TBL] [Abstract][Full Text] [Related]
29. JAB1 is essential for B cell development and germinal center formation and inversely regulates Fas ligand and Bcl6 expression.
Sitte S; Gläsner J; Jellusova J; Weisel F; Panattoni M; Pardi R; Gessner A
J Immunol; 2012 Mar; 188(6):2677-86. PubMed ID: 22327073
[TBL] [Abstract][Full Text] [Related]
30. BCL6 modulates tonic BCR signaling in diffuse large B-cell lymphomas by repressing the SYK phosphatase, PTPROt.
Juszczynski P; Chen L; O'Donnell E; Polo JM; Ranuncolo SM; Dalla-Favera R; Melnick A; Shipp MA
Blood; 2009 Dec; 114(26):5315-21. PubMed ID: 19855081
[TBL] [Abstract][Full Text] [Related]
31. MYC/BCL6 double-hit lymphoma (DHL): a tumour associated with an aggressive clinical course and poor prognosis.
Li S; Desai P; Lin P; Yin CC; Tang G; Wang XJ; Konoplev SN; Khoury JD; Bueso-Ramos CE; Medeiros LJ
Histopathology; 2016 Jun; 68(7):1090-8. PubMed ID: 26426741
[TBL] [Abstract][Full Text] [Related]
32. Chemically Induced Degradation of the Oncogenic Transcription Factor BCL6.
Kerres N; Steurer S; Schlager S; Bader G; Berger H; Caligiuri M; Dank C; Engen JR; Ettmayer P; Fischerauer B; Flotzinger G; Gerlach D; Gerstberger T; Gmaschitz T; Greb P; Han B; Heyes E; Iacob RE; Kessler D; Kölle H; Lamarre L; Lancia DR; Lucas S; Mayer M; Mayr K; Mischerikow N; Mück K; Peinsipp C; Petermann O; Reiser U; Rudolph D; Rumpel K; Salomon C; Scharn D; Schnitzer R; Schrenk A; Schweifer N; Thompson D; Traxler E; Varecka R; Voss T; Weiss-Puxbaum A; Winkler S; Zheng X; Zoephel A; Kraut N; McConnell D; Pearson M; Koegl M
Cell Rep; 2017 Sep; 20(12):2860-2875. PubMed ID: 28930682
[TBL] [Abstract][Full Text] [Related]
33. Primary mediastinal B-cell lymphoma: hypermutation of the BCL6 gene targets motifs different from those in diffuse large B-cell and follicular lymphomas.
Malpeli G; Barbi S; Moore PS; Scardoni M; Chilosi M; Scarpa A; Menestrina F
Haematologica; 2004 Sep; 89(9):1091-9. PubMed ID: 15377470
[TBL] [Abstract][Full Text] [Related]
34. CD137L and CD4 T cells limit BCL6-expressing pre-germinal center B cell expansion and BCL6-driven B cell malignancy.
Ding Z; Quast I; Yan F; Liao Y; Pitt C; O-Donnell K; Robinson MJ; Shi W; Kallies A; Zotos D; Tarlinton DM
Immunol Cell Biol; 2022 Oct; 100(9):705-717. PubMed ID: 35916066
[TBL] [Abstract][Full Text] [Related]
35. p110δ phosphoinositide 3-kinase represses IgE switch by potentiating BCL6 expression.
Zhang TT; Makondo KJ; Marshall AJ
J Immunol; 2012 Apr; 188(8):3700-8. PubMed ID: 22422878
[TBL] [Abstract][Full Text] [Related]
36. Small-molecule-induced polymerization triggers degradation of BCL6.
Słabicki M; Yoon H; Koeppel J; Nitsch L; Roy Burman SS; Di Genua C; Donovan KA; Sperling AS; Hunkeler M; Tsai JM; Sharma R; Guirguis A; Zou C; Chudasama P; Gasser JA; Miller PG; Scholl C; Fröhling S; Nowak RP; Fischer ES; Ebert BL
Nature; 2020 Dec; 588(7836):164-168. PubMed ID: 33208943
[TBL] [Abstract][Full Text] [Related]
37. CRISPR/Cas9 Screens Reveal Multiple Layers of B cell CD40 Regulation.
Jiang C; Trudeau SJ; Cheong TC; Guo R; Teng M; Wang LW; Wang Z; Pighi C; Gautier-Courteille C; Ma Y; Jiang S; Wang C; Zhao B; Paillard L; Doench JG; Chiarle R; Gewurz BE
Cell Rep; 2019 Jul; 28(5):1307-1322.e8. PubMed ID: 31365872
[TBL] [Abstract][Full Text] [Related]
38. Rationally designed BCL6 inhibitors target activated B cell diffuse large B cell lymphoma.
Cardenas MG; Yu W; Beguelin W; Teater MR; Geng H; Goldstein RL; Oswald E; Hatzi K; Yang SN; Cohen J; Shaknovich R; Vanommeslaeghe K; Cheng H; Liang D; Cho HJ; Abbott J; Tam W; Du W; Leonard JP; Elemento O; Cerchietti L; Cierpicki T; Xue F; MacKerell AD; Melnick AM
J Clin Invest; 2016 Sep; 126(9):3351-62. PubMed ID: 27482887
[TBL] [Abstract][Full Text] [Related]
39. UCH-L1 is induced in germinal center B cells and identifies patients with aggressive germinal center diffuse large B-cell lymphoma.
Bedekovics T; Hussain S; Feldman AL; Galardy PJ
Blood; 2016 Mar; 127(12):1564-74. PubMed ID: 26702068
[TBL] [Abstract][Full Text] [Related]
40. An expanding job description for bcl6.
Bi E; Ye BH
J Mol Cell Biol; 2010 Feb; 2(1):5-7. PubMed ID: 19797315
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
